PL2773348T3 - Kompozycja farmaceutyczna omeprazolu - Google Patents

Kompozycja farmaceutyczna omeprazolu

Info

Publication number
PL2773348T3
PL2773348T3 PL12780735T PL12780735T PL2773348T3 PL 2773348 T3 PL2773348 T3 PL 2773348T3 PL 12780735 T PL12780735 T PL 12780735T PL 12780735 T PL12780735 T PL 12780735T PL 2773348 T3 PL2773348 T3 PL 2773348T3
Authority
PL
Poland
Prior art keywords
omeprazole
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PL12780735T
Other languages
English (en)
Inventor
Jaume SANGRÀ PEREZ
Cristina ALCOCER ARANZANA
Original Assignee
Laboratorios Del. Dr. Esteve, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del. Dr. Esteve, S.A. filed Critical Laboratorios Del. Dr. Esteve, S.A.
Publication of PL2773348T3 publication Critical patent/PL2773348T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL12780735T 2011-11-02 2012-10-31 Kompozycja farmaceutyczna omeprazolu PL2773348T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11382336 2011-11-02
EP12780735.2A EP2773348B1 (en) 2011-11-02 2012-10-31 Pharmaceutical composition of omeprazole
PCT/EP2012/071553 WO2013064535A1 (en) 2011-11-02 2012-10-31 Pharmaceutical composition of omeprazole

Publications (1)

Publication Number Publication Date
PL2773348T3 true PL2773348T3 (pl) 2018-07-31

Family

ID=47115965

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12780735T PL2773348T3 (pl) 2011-11-02 2012-10-31 Kompozycja farmaceutyczna omeprazolu

Country Status (14)

Country Link
US (1) US20140255503A1 (pl)
EP (1) EP2773348B1 (pl)
AU (1) AU2012331182B2 (pl)
BR (1) BR112014009580B1 (pl)
CA (1) CA2851327C (pl)
ES (1) ES2667402T3 (pl)
HK (1) HK1201477A1 (pl)
HR (1) HRP20180567T1 (pl)
HU (1) HUE036400T2 (pl)
PL (1) PL2773348T3 (pl)
PT (1) PT2773348T (pl)
RU (1) RU2647472C2 (pl)
SI (1) SI2773348T1 (pl)
WO (1) WO2013064535A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CA3033065A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
US20190125676A1 (en) * 2017-11-02 2019-05-02 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors for oral administration
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
CN114432270A (zh) * 2020-10-30 2022-05-06 康普药业股份有限公司 一种奥美拉唑肠溶制剂
CN116807990B (zh) * 2023-05-26 2024-09-24 桂林华信制药有限公司 艾司奥美拉唑镁肠溶胶囊及其制备方法
CN118649151B (zh) * 2024-06-28 2025-06-24 海南恒诚三叶制药有限公司 奥美拉唑肠溶胶囊及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DK1078628T3 (da) * 1994-07-08 2009-02-23 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
ES2244167T3 (es) * 1999-12-16 2005-12-01 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos.
EP1530460A2 (en) * 2002-08-16 2005-05-18 Themis Laboratories Private Limited A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
US8697094B2 (en) * 2002-10-16 2014-04-15 Takeda Pharmaceutical Company Limited Stable solid preparations
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
AU2003245033A1 (en) * 2003-05-08 2004-11-26 Podili Khadgapathi An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation
CN100490790C (zh) * 2007-04-28 2009-05-27 杭州民生药业集团有限公司 一种奥美拉唑肠溶微丸胶囊及其制备方法
EP2319504A1 (en) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical solid dosage form
CN103402501A (zh) * 2010-12-29 2013-11-20 雷迪博士实验室有限公司 调节释放的苯并咪唑制剂

Also Published As

Publication number Publication date
WO2013064535A1 (en) 2013-05-10
US20140255503A1 (en) 2014-09-11
BR112014009580B1 (pt) 2022-03-29
AU2012331182A1 (en) 2014-04-17
RU2014122135A (ru) 2015-12-10
ES2667402T3 (es) 2018-05-10
HRP20180567T1 (hr) 2018-05-18
EP2773348B1 (en) 2018-02-21
BR112014009580A2 (pt) 2017-05-09
AU2012331182B2 (en) 2016-05-12
SI2773348T1 (en) 2018-05-31
RU2647472C2 (ru) 2018-03-15
PT2773348T (pt) 2018-04-16
HUE036400T2 (hu) 2018-07-30
HK1201477A1 (en) 2015-09-04
CA2851327C (en) 2019-06-25
CA2851327A1 (en) 2013-05-10
EP2773348A1 (en) 2014-09-10

Similar Documents

Publication Publication Date Title
IL276012A (en) Pharmaceutical preparations containing sorbitan esters
AP3864A (en) Pharmaceutical composition
IL230010B (en) Inhalable pharmaceutical ingredients
GB201113662D0 (en) Pharmaceutical compositions
AP3656A (en) Pharmaceutical compositions
ZA201308208B (en) Pharmaceutical compositions
GB201118232D0 (en) Pharmaceutical composition
SI2691083T1 (sl) Farmacevtski sestavek sitagliptina
PT2773348T (pt) Composição farmacêutica de omeprazol
ZA201308157B (en) Pharmaceutical composition
ZA201307593B (en) Antihypertensive pharmaceutical composition
EP2709593A4 (en) PHARMACEUTICAL COMPOSITION OF MULTIPLE PARTICLES
ZA201305227B (en) Pharmaceutical composition comprising pyridone derivatives
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
GB201118181D0 (en) Pharmaceutical compositions
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
HUE038538T2 (hu) Drotaverint tartalmazó gyógyszerészeti készítmény
EP2665480A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING THEM
HUP1100444A2 (en) Pharmaceutical composition
ZA201308414B (en) Solid pharmaceutical composition
HUP1100445A2 (en) Pharmaceutical composition
GB201407689D0 (en) Pharmaceutical compositions of antihypertensives
ZA201309732B (en) Process for the preparation of dexlansoprazole
ZA201309537B (en) Pharmaceutical composition comprising fexofedine
SG11201401570YA (en) Pharmaceutical compositions of resveratrol